Polyarteritis nodosa: Difference between revisions

No edit summary
 
(17 intermediate revisions by 5 users not shown)
Line 1: Line 1:
==Background==
==Background==
* Necrotizing vasculitis of small- and medium-sized blood vessels
*Necrotizing [[vasculitis]] of small- and medium-sized blood vessels
* Skin, musculoskeletal, CNS, and GI tract (spares lung)
*Skin, musculoskeletal, CNS, and GI tract (spares lung)
* Predilection to arterial bifurcations and branch sites
*Predilection to arterial bifurcations and branch sites
* Microaneurysm, thrombosis, emboli, organic ischemia, and infarction
*Microaneurysm, [[thromboembolism|thrombosis, emboli]], organ ischemia, and infarction
* Etiology: Idiopathic, HBV, HCV, hairy cell leukemia
*Etiology: Idiopathic, [[HBV]], [[hepatitis C|HCV]], hairy cell [[leukemia]]


==Diagnosis==
{{Primary Vasculitis DDX}}
===Clinical Features===
* Cutaneous lesion + adult onset HTN
* Men > women (2:1)
* Peak age 40-60s
* Systemic: Fatigue, weight loss, weakness, fever, arthralgia
* Cutaneous lesions (1/3 patients)
** Tender erythematous nodules
** Palpable pupura (fingers, ankles, malleoli, pretibial)
** Digital cyanosis
** Splinter hemorrhages
** Livedo reticularis
* Renovascular arteritis → HTN
* Peripheral neuropathies (mononeuritis multiplex, polyneuropathy)
* Mesenteric vasculitis (abdominal angina, ischemia, infarction, perforation)
* Myocardial ischemia and heart failure
* Myalgia (elevated CK)


===Classification ===
==Clinical Features==
* American College of Rheumatology 10 criteria (at least 3, has 82% sensitivity and 87% specificity)  
[[File:PMC3505767 ad-24-383-g005.png|thumb|Cutaneous polyarteritis nodosa. (A) The patient presented with livedo reticularis on the lower legs. (B) Vasculitis involves the muscular artery of the deep dermis.]]
** Unexplained weight loss greater than 4kg
*Cutaneous [[rash|lesion]] + adult onset [[hypertension]]
** Livedo reticularis
*Men > women (2:1)
** Testicular pain or tenderness
*Peak age 40-60s
** Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
*Systemic: Fatigue, weight loss, weakness, [[fever]], [[arthralgia]]
** Mononeuropathy or polyneuropathy
*Cutaneous lesions (1/3 patients)
** New-onset diastolic blood pressure > 90mmHg
**Tender erythematous nodules
** Elevated serum BUN (>40mg/dL or 14.3mmol/L) or Cr (>1.5mg/dL or 132 mmol/L)
**Palpable [[purpura]] (fingers, ankles, malleoli, pretibial)
** Evidence of HBV infection (serology)
**Digital cyanosis
** Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
**Splinter hemorrhages
** Biopsy of small- or medium-sized artery containing polymorphonuclear cells
**Livedo reticularis
*Renovascular arteritis → [[hypertension]]
*Peripheral neuropathies (mononeuritis multiplex, polyneuropathy)
*Mesenteric vasculitis (abdominal angina, [[mesenteric ischemia|ischemia]], infarction, perforation)
*[[Myocardial ischemia]] and [[heart failure]]
*[[Myalgia]] (elevated CK)


==Workup==
==Differential Diagnosis==
* Definitive: Tissue biopsy
*Embolism, thrombosis, atherosclerosis
* Labs:
*[[HIV]], [[Hepatitis]], IE, [[mycotic aneurysm]]
** Cr, CK, LFT (elevated)
*Fibromuscular dysplasia
** CBC (Leukocytosis, normochromic anemia, thrombocytosis)
*Microscopic polyangiitis, [[Granulomatosis with polyangiitis]] (Wegener's), [[Eosinophilic granulomatosis with polyangiitis]] (Churg-Strauss), IgA vasculitis, drug-induced vasculitis, [[connective tissue disease]], [[SLE]], cryoglobulinemic vasculitis
** Hepatitis serology
** UA (proteinuria)
** ESR/CRP
* Imaging
** Angiography preferred: aneurysm or stenosis of medium-sized vessels
** Arteriograms
** CT/MRI
*To consider: CXR, blood cx, autoimmune serologic testing (ANCA, ANA, RF) to r/o other diseases


==Differential Diagnosis==
==Evaluation==
* Embolism, thrombosis, atherosclerosis
===Workup===
* [[HIV]], [[Hepatitis]], IE, mycotic aneurysm
*Definitive: Tissue biopsy
* Fibromuscular dysplagia
*Labs:
* Microscopic polyangiitis, Wegener's, Chug-Strauss, IgA vasculitis, drug-induced vasculitis, connective tissue disease, SLE, cryoglobulinemic vasculitis
**Cr, CK, [[LFTs]] (elevated)
**CBC ([[Leukocytosis]], normochromic [[anemia]], [[thrombocytosis]])
**[[viral hepatitis|Hepatitis serology]]
**[[Urinalysis]] ([[proteinuria]])
**ESR/CRP
*Imaging
**Angiography preferred: aneurysm or stenosis of medium-sized vessels
**Arteriograms
**CT/MRI
*Consider: [[CXR]], blood cultures, autoimmune serologic testing (ANCA, ANA, RF) to rule out other diseases
 
===Diagnosis===
====American College of Rheumatology Criteria====
''Need at least 3/10 (82% sensitivity and 87% specificity)''
*Unexplained weight loss greater than 4kg
*Livedo reticularis
*[[Testicular Pain]] or tenderness
*Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
*Mononeuropathy or polyneuropathy
*New-onset diastolic blood pressure > 90mmHg
*Elevated serum BUN (>40mg/dL or 14.3mmol/L) or creatinine (>1.5mg/dL or 132 mmol/L)
*Evidence of HBV infection (serology)
*Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
*Biopsy of small- or medium-sized artery containing polymorphonuclear cells


==Management==
==Management==
* Rheumatology consult
*Rheumatology consult
* May warrant surgical intervention if abdominal involvement
*May warrant surgical intervention if abdominal involvement
* Corticosteroid:  
*[[Corticosteroids]]:  
** [[Prednisone]] 1mg/kg  
**[[Prednisone]] 1mg/kg  
** [[Methylprednisolone]] (7-15mg/kg, max 1000mg IV) for severe, organ threatening
**[[Methylprednisolone]] (7-15mg/kg, max 1000mg IV) for severe, organ threatening
* Immunosuppressive agent for moderate to severe
*Immunosuppressive agent for moderate to severe
**Cyclophosphamide (600mg/m2<sup>) q2weeks x 3 doses
**[[Cyclophosphamide]] (600mg/m2<sup>) q2weeks x 3 doses
* ACEI or ARB for HTN
*[[ACEI]] or [[ARB]] for hypertension


==Sources==
==References==
<references/>
<references/>
*Reference: Rosen's Emergency Medicine 8th edition. 2013. Chapter: Erythematosus and the Vasculitides. p1539-1540.
*Reference: Rosen's Emergency Medicine 8th edition. 2013. Chapter: Erythematosus and the Vasculitides. p1539-1540.
* Merkel PA, et al. Clinical manifestations and diagnosis of polyarteritis nodosa in adults. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
*Merkel PA, et al. Clinical manifestations and diagnosis of polyarteritis nodosa in adults. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
* Merkel PA, et al. Treatment and prognosis of polyarteritis nodosa. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
*Merkel PA, et al. Treatment and prognosis of polyarteritis nodosa. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
*Jacobs-Kosmin, D. (2014, Dec 12). Polyarteritis Nodosa. eMedicine. Retrieved 12/22/2014 from http://emedicine.medscape.com/article/330717-overview.
*Jacobs-Kosmin, D. (2014, Dec 12). Polyarteritis Nodosa. eMedicine. Retrieved 12/22/2014 from http://emedicine.medscape.com/article/330717-overview.


[[Category:Rheum]]
[[Category:Rheumatology]]
[[Category:Vascular]]

Latest revision as of 17:35, 2 August 2023

Background

  • Necrotizing vasculitis of small- and medium-sized blood vessels
  • Skin, musculoskeletal, CNS, and GI tract (spares lung)
  • Predilection to arterial bifurcations and branch sites
  • Microaneurysm, thrombosis, emboli, organ ischemia, and infarction
  • Etiology: Idiopathic, HBV, HCV, hairy cell leukemia

Vasculitis Syndrome Types

Clinical Features

Cutaneous polyarteritis nodosa. (A) The patient presented with livedo reticularis on the lower legs. (B) Vasculitis involves the muscular artery of the deep dermis.
  • Cutaneous lesion + adult onset hypertension
  • Men > women (2:1)
  • Peak age 40-60s
  • Systemic: Fatigue, weight loss, weakness, fever, arthralgia
  • Cutaneous lesions (1/3 patients)
    • Tender erythematous nodules
    • Palpable purpura (fingers, ankles, malleoli, pretibial)
    • Digital cyanosis
    • Splinter hemorrhages
    • Livedo reticularis
  • Renovascular arteritis → hypertension
  • Peripheral neuropathies (mononeuritis multiplex, polyneuropathy)
  • Mesenteric vasculitis (abdominal angina, ischemia, infarction, perforation)
  • Myocardial ischemia and heart failure
  • Myalgia (elevated CK)

Differential Diagnosis

Evaluation

Workup

Diagnosis

American College of Rheumatology Criteria

Need at least 3/10 (82% sensitivity and 87% specificity)

  • Unexplained weight loss greater than 4kg
  • Livedo reticularis
  • Testicular Pain or tenderness
  • Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
  • Mononeuropathy or polyneuropathy
  • New-onset diastolic blood pressure > 90mmHg
  • Elevated serum BUN (>40mg/dL or 14.3mmol/L) or creatinine (>1.5mg/dL or 132 mmol/L)
  • Evidence of HBV infection (serology)
  • Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
  • Biopsy of small- or medium-sized artery containing polymorphonuclear cells

Management

References

  • Reference: Rosen's Emergency Medicine 8th edition. 2013. Chapter: Erythematosus and the Vasculitides. p1539-1540.
  • Merkel PA, et al. Clinical manifestations and diagnosis of polyarteritis nodosa in adults. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
  • Merkel PA, et al. Treatment and prognosis of polyarteritis nodosa. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
  • Jacobs-Kosmin, D. (2014, Dec 12). Polyarteritis Nodosa. eMedicine. Retrieved 12/22/2014 from http://emedicine.medscape.com/article/330717-overview.